ZWJ Investment Counsel’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.7M | Sell |
89,795
-513
| -0.6% | -$190K | 1.12% | 33 |
|
|
2026
Q1 | $26.4M | Sell |
90,308
-8,590
| -9% | -$2.82M | 0.95% | 43 |
|
|
2025
Q4 | $34.7M | Buy |
98,898
+3,912
| +4% | +$1.32M | 1.25% | 29 |
|
|
2025
Q3 | $30.7M | Sell |
94,986
-29,145
| -23% | -$9.06M | 1.08% | 39 |
|
|
2025
Q2 | $48.3M | Buy |
124,131
+1,299
| +1% | +$522K | 1.79% | 23 |
|
|
2025
Q1 | $53.4M | Buy |
122,832
+5,106
| +4% | +$2.05M | 2.17% | 16 |
|
|
2024
Q4 | $43.4M | Buy |
117,726
+8,664
| +8% | +$3.63M | 1.79% | 21 |
|
|
2024
Q3 | $56.7M | Buy |
109,062
+1,733
| +2% | +$926K | 2.32% | 9 |
|
|
2024
Q2 | $58.2M | Buy |
107,329
+2,245
| +2% | +$1.19M | 2.55% | 8 |
|
|
2024
Q1 | $54.5M | Buy |
105,084
+2,477
| +2% | +$1.23M | 2.48% | 8 |
|
|
2023
Q4 | $48.4M | Buy |
102,607
+255
| +0.2% | +$118K | 2.49% | 9 |
|
|
2023
Q3 | $44.6M | Buy |
+102,352
| New | +$46.4M | 2.47% | 10 |
|
|
2023
Q2 | – | Sell |
-95,142
| Closed | -$43.7M | – | 205 |
|
|
2023
Q1 | $43.7M | Sell |
95,142
-9,450
| -9% | -$4.5M | 2.41% | 9 |
|
|
2022
Q4 | $53.7M | Sell |
104,592
-2,087
| -2% | -$1.06M | 3.03% | 3 |
|
|
2022
Q3 | $48.5M | Sell |
106,679
-215
| -0.2% | -$103K | 3.05% | 2 |
|
|
2022
Q2 | $51.6M | Sell |
106,894
-2,701
| -2% | -$1.34M | 3.01% | 2 |
|
|
2022
Q1 | $53.8M | Sell |
109,595
-8,595
| -7% | -$3.93M | 2.85% | 5 |
|
|
2021
Q4 | $54.8M | Buy |
+118,190
| New | +$49.7M | 2.8% | 6 |
|
|
2021
Q3 | – | Sell |
-119,906
| Closed | -$45.8M | – | 183 |
|
|
2021
Q2 | $45.8M | Sell |
119,906
-1,215
| -1% | -$464K | 2.65% | 6 |
|
|
2021
Q1 | $43.5M | Sell |
121,121
-3,919
| -3% | -$1.26M | 2.67% | 7 |
|
|
2020
Q4 | $40.1M | Buy |
125,040
+2,209
| +2% | +$678K | 2.73% | 7 |
|
|
2020
Q3 | $33M | Sell |
122,831
-2,564
| -2% | -$690K | 2.64% | 8 |
|
|
2020
Q2 | $33M | Buy |
125,395
+6,222
| +5% | +$1.66M | 2.86% | 8 |
|
|
2020
Q1 | $27.1M | Sell |
119,173
-633
| -0.5% | -$173K | 2.42% | 13 |
|
|
2019
Q4 | $36.2M | Sell |
119,806
-6,002
| -5% | -$1.65M | 2.44% | 8 |
|
|
2019
Q3 | $30.2M | Buy |
125,808
+3,969
| +3% | +$1.09M | 2.36% | 12 |
|
|
2019
Q2 | $34.4M | Buy |
121,839
+7,736
| +7% | +$2.11M | 2.7% | 5 |
|
|
2019
Q1 | $32.7M | Sell |
114,103
-3,117
| -3% | -$901K | 2.7% | 7 |
|
|
2018
Q4 | $30.8M | Sell |
117,220
-402
| -0.3% | -$111K | 2.9% | 7 |
|
|
2018
Q3 | $32.2M | Buy |
117,622
+372
| +0.3% | +$96.6K | 2.62% | 7 |
|
|
2018
Q2 | $27.9M | Buy |
117,250
+1,037
| +0.9% | +$240K | 2.41% | 12 |
|
|
2018
Q1 | $25.5M | Sell |
116,213
-2,494
| -2% | -$586K | 2.3% | 13 |
|
|
2017
Q4 | $26.7M | Sell |
118,707
-805
| -0.7% | -$171K | 2.11% | 12 |
|
|
2017
Q3 | $22.7M | Buy |
119,512
+1,628
| +1% | +$310K | 1.77% | 23 |
|
|
2017
Q2 | $22.2M | Buy |
117,884
+516
| +0.4% | +$92.7K | 1.77% | 19 |
|
|
2017
Q1 | $19.4M | Buy |
117,368
+18,670
| +19% | +$2.97M | 1.59% | 24 |
|
|
2016
Q4 | $14.2M | Buy |
98,698
+21,850
| +28% | +$2.93M | 1.36% | 33 |
|
|
2016
Q3 | $9.63M | Buy |
76,848
+75,315
| +4,913% | +$9.72M | 0.96% | 45 |
|
|
2016
Q2 | $201K | Hold |
1,533
| – | – | 0.02% | 149 |
|
|
2016
Q1 | $213K | Buy |
+1,533
| New | +$205K | 0.02% | 145 |
|
Other funds holding ELV
AACR
HGIM
FI
DC
CF
MIHAS
ZWJ Investment Counsel's ELV Position: Q2 2026 in Review
ZWJ Investment Counsel reduced its Elevance Health (ELV) stake by 0.57% in Q2 2026, selling an estimated $190K and leaving 89,795 shares worth $34.7M. The position accounts for 1.12% of the portfolio, ranked #33.
ZWJ Investment Counsel first reported a position in ELV in Q1 2016 and has held it in 40 quarters since. The position peaked at $58.2M in Q2 2024. 565 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- ZWJ Investment Counsel held 89,795 shares of Elevance Health worth $34.7M as of Q2 2026.
- ZWJ Investment Counsel sold 513 Elevance Health shares in Q2 2026, an estimated $190K.
- Elevance Health made up 1.12% of ZWJ Investment Counsel's portfolio in Q2 2026, its #33 holding.
- ZWJ Investment Counsel first reported a position in Elevance Health in Q1 2016 and has held it in 40 quarters since.
- ZWJ Investment Counsel's Elevance Health position peaked at $58.2M in Q2 2024.
- 565 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.